Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
12:35pm, Thursday, 21'st Aug 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investors concerning the Co
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) on behalf of investors concerning the
AVITA Medical Successfully Completes Australian Equity Raise
08:30am, Tuesday, 12'th Aug 2025
Private placement of approximately 17.2 million new CHESS Depositary Interests (“New CDIs”) quoted on the Australian Securities Exchange (ASX) Issue price of A$1.32 per New CDI, raising approximat
AVITA Medical to Host Investor Webinar Briefing
07:00pm, Sunday, 10'th Aug 2025
VALENCIA, Calif., Aug. 10, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholde
AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript
03:21pm, Friday, 08'th Aug 2025
AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Ben Atkins - Corporate Participant David O'Toole - Chief Financial Officer James M. C
Avita Medical (RCEL) Q2 Sales Up 21%
10:26pm, Thursday, 07'th Aug 2025
Avita Medical (RCEL) Q2 Sales Up 21%
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
04:05pm, Thursday, 07'th Aug 2025
VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported fin
AVITA Medical to Announce Second Quarter 2025 Financial Results
04:05pm, Monday, 28'th Jul 2025
VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solu
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
08:00pm, Tuesday, 03'rd Jun 2025
VALENCIA, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, tod
AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript
09:50pm, Thursday, 08'th May 2025
AVITA Medical, Inc. (NASDAQ:RCEL ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director, Investor Relations Jim Corbett - Chief Executive Officer Dav
AVITA Medical Reports First Quarter 2025 Financial Results
04:03pm, Thursday, 08'th May 2025
VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported fina
AVITA Medical to Announce First Quarter 2025 Financial Results
04:05pm, Thursday, 17'th Apr 2025
VALENCIA, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound company delivering transformative solutions, today announced that i
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
04:05pm, Wednesday, 09'th Apr 2025
VALENCIA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, to
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
04:03pm, Thursday, 03'rd Apr 2025
VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced t
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
04:05pm, Monday, 17'th Mar 2025
AVITA Medical announces new manufacturing agreement and amended distribution agreement with Stedical Scientific to further commercialization of PermeaDerm.
